Physicochemical Descriptors

Property Name Value
Molecular Formula C12H22FeO11
Molecular Weight 398.14
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
None Supplement

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hypertension, Pulmonary 2 D006976 ClinicalTrials
Hematologic Neoplasms 2 D019337 ClinicalTrials

Related Entries

MCS

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
16.37
Cardiac disorders
9.24
Injury, poisoning and procedural complications
9.24
Skin and subcutaneous tissue disorders
9.04
Vascular disorders
8.83
Nervous system disorders
7.55
Gastrointestinal disorders
6.77
Respiratory, thoracic and mediastinal disorders
6.2
Immune system disorders
4.7
Musculoskeletal and connective tissue disorders
4.32
Investigations
3.94
Metabolism and nutrition disorders
2.45
Pregnancy, puerperium and perinatal conditions
2.31

Cross References

Resources Reference
CAS NUMBER 8047-67-4
ChEMBL CHEMBL1200823
FDA SRS FZ7NYF5N8L
PubChem 49800026
SureChEMBL SCHEMBL106974